Neuren Pharmaceuticals Limited (ASX:NEU)
Australia
· Delayed Price · Currency is AUD
12.75
+1.07 (9.16%)
Mar 10, 2026, 4:10 PM AEST
Neuren Pharmaceuticals Cash Flow Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | 30.44 | 142.04 | 157.08 | 0.18 | -7.79 | |
| Depreciation & Amortization | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |
| Loss (Gain) From Sale of Investments | 3.3 | -3.59 | 1.53 | 0.7 | - | |
| Stock-Based Compensation | 3.67 | 1.23 | 2.93 | 1.99 | 0.84 | |
| Other Operating Activities | -8.03 | 10.44 | 0.14 | 0.18 | -0.4 | |
| Change in Accounts Receivable | 154.59 | -157.11 | -13.11 | 0.19 | -2.51 | |
| Change in Accounts Payable | -0.49 | -0.48 | - | 0.34 | -0.11 | |
| Change in Income Taxes | -48.91 | -3.83 | 36.35 | - | - | |
| Change in Other Net Operating Assets | -9.17 | - | - | - | - | |
| Operating Cash Flow | 125.42 | -11.27 | 184.93 | 3.6 | -9.97 | |
| Operating Cash Flow Growth | - | - | 5038.23% | - | - | |
| Capital Expenditures | -0.04 | -0.01 | -0.04 | -0.02 | -0.01 | |
| Investment in Securities | -87.97 | 4.14 | -211.45 | - | - | |
| Investing Cash Flow | -88.01 | 4.13 | -211.49 | -0.02 | -0.01 | |
| Issuance of Common Stock | 6.39 | 1.66 | 3.64 | - | 23.28 | |
| Repurchase of Common Stock | -39.57 | -10.43 | - | - | - | |
| Other Financing Activities | -0.04 | -0.01 | -0.02 | -0 | -1.11 | |
| Financing Cash Flow | -33.22 | -8.78 | 3.62 | -0 | 22.18 | |
| Foreign Exchange Rate Adjustments | -3.12 | 1.97 | -0.15 | -0.18 | 0.4 | |
| Net Cash Flow | 1.07 | -13.94 | -23.09 | 3.4 | 12.6 | |
| Free Cash Flow | 125.39 | -11.28 | 184.89 | 3.58 | -9.98 | |
| Free Cash Flow Growth | - | - | 5064.39% | - | - | |
| Free Cash Flow Margin | 193.95% | -5.20% | 79.71% | 23.22% | -312.17% | |
| Free Cash Flow Per Share | 0.96 | -0.09 | 1.41 | 0.03 | -0.08 | |
| Cash Income Tax Paid | 54.15 | 37.22 | -0.88 | -1.39 | -2.52 | |
| Levered Free Cash Flow | 116.98 | -42.25 | 152.97 | 2.59 | -6.76 | |
| Unlevered Free Cash Flow | 116.98 | -42.25 | 152.97 | 2.59 | -6.76 | |
| Change in Working Capital | 96.02 | -161.42 | 23.24 | 0.53 | -2.62 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.